Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
High Content Screening, whether target-driven or purely phenotypic, is cost intensive and time consuming, ...
Presenter: Christian Schueller
Using phenotypic screens as a strategy to identify ...
See how TIBCO Spotfire helps identify cellular phenotypic responses of interest in High Content Screening ...
Learn how to group cellular image results representing similar phenotypic responses in TIBCO Spotfire and ...
Dynamically visualize the correlation between dose response and cellular phenotypic parameters with TIBCO ...